KTU PharmAI

Affiliations · Innovative AI for Pharmacology · Translational Data Science

prof_pic.jpg

PharmAI Research Group

Karadeniz Technical University

Drug and Pharmaceutical Technology Application & Research Center (ILAFAR)

Kanuni Campus, 61080 Trabzon, Türkiye

hulya@ktu.edu.tr

Mission

We advance pharmacology by designing innovative AI and data-driven methods that enhance and accelerate traditional experimental workflows—from hypothesis generation to mechanism-of-action (MoA) inference and preclinical decision-making.

Who we are

PharmAI (Innovative AI Applications in Pharmacology) is a collaborative research group spanning artificial intelligence, deep learning, signal & image processing, and experimental pharmacology. Our projects are led by researchers with complementary expertise in vision transformers, multimodal learning, biomedical signal analysis, and pharmacometrics.

Primary affiliations

  • KTÜ ILAFAR — Drug and Pharmaceutical Technology Application & Research Center
  • Trabzon University — Department of Artificial Intelligence Engineering
  • Collaborative ties with national and international partners in academia, clinics, and industry

Research focus

  • Multimodal Pharmacology AI
    Integrating ultrasound & microscopy images, clinical text/metadata, and time-series contractility signals to model drug effects, safety, and efficacy.

  • MoA & DDI Modeling
    Learning mechanism-of-action representations and drug–drug interaction (DDI) risks using transformer-based architectures, cross-attention, and correlation-matrix reasoning.

  • Biomedical Imaging & EDOF
    Vision-transformer approaches for Extended Depth of Focus (EDOF), shape-from-focus, and task-driven image fusion in microscopic systems.

  • Domain Generalization & Robustness
    Methods that generalize across devices, centers, and cohorts, with rigorous ablations and calibration analysis.

Approach & toolset

  • Architectures: ViT/PVT/Swin variants, CNN-Transformers, BERT/clinical language models, cross-attention fusion, correlation-matrix reasoning
  • Data: biomedical images (ultrasound, microscopy), contractility time-series, curated clinical descriptors
  • Practices: reproducible pipelines, cross-validation, stratified evaluation, lightweight deployment

Facilities

We maintain GPU-accelerated training infrastructure and secure data pipelines for clinical collaboration. Our wet-lab partners provide controlled experimental protocols and validated annotations to support model development.

Open collaboration

We actively collaborate with clinicians, pharmacologists, and industry R&D teams.
Interested in joining as a student, visiting scholar, or partner lab? Reach out at hulya@ktu.edu.tr with a short bio and interests.

Selected highlights

  • PVT-EDOF for Microscopy — Vision-transformer pipelines for extended depth-of-focus reconstruction and optimal image fusion.
  • Contractility Signal Intelligence — 1D/2D deep models on pharmacodynamic time-series and Gram-based transforms for MoA-aware readouts.

Ethics & data governance

We follow institutional and national ethics guidelines, emphasize privacy-preserving methods, and report dataset characteristics, limitations, and potential biases. Where applicable, IRB/ethics approvals and informed-consent procedures are observed.


This page auto-lists selected publications and recent posts if available in your repository. To feature works, mark entries in _bibliography/papers.bib with selected={true}; news items go in _news/, and posts in _posts/.

news

Jan 15, 2016 A simple inline announcement with Markdown emoji! :sparkles: :smile:
Nov 07, 2015 A long announcement with details
Oct 22, 2015 A simple inline announcement.

latest posts

selected publications

  1. Can Quantum-Mechanical Description of Physical Reality Be Considered Complete?
    A. Einstein*†, B. Podolsky*, and N. Rosen*
    Phys. Rev., New Jersey. More Information can be found here , May 1935